IRVINE, Calif.--(BUSINESS WIRE)--Diality, a medical device company offering the Moda-flx Hemodialysis System™, today announced that it has joined Kidney Care Partners, the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers..

加利福尼亚州欧文市（商业新闻短讯）--提供Moda flx血液透析系统™的医疗器械公司Diality今天宣布，它已加入肾脏护理合作伙伴，肾脏护理合作伙伴是美国领先的肾脏护理多方利益相关者联盟，代表患者倡导者、医生组织、健康专业团体、透析提供者、研究人员和制造商。

“Diality is proud to become a member of an organization like Kidney Care Partners,” said Dan Guthrie, Chief Business Officer at Diality. “Kidney Care Partners’ dedication to patient-centered care and innovation within kidney care is perfectly aligned with Diality’s mission of improving lives impacted by kidney disease.

。“肾脏护理合作伙伴致力于以患者为中心的护理和肾脏护理创新，这与Diality改善受肾脏疾病影响的生活的使命完全一致。

We look forward to contributing to Kidney Care Partners’ legislative agenda.”.

我们期待着为肾脏护理合作伙伴的立法议程做出贡献。”

“Kidney Care Partners is thrilled to welcome Diality, a hemodialysis innovator who brings an important voice to our coalition,” said Mahesh Krishnan, MD, MPH, MBA, Chair of Kidney Care Partners. “Together, we look forward to advancing initiatives that promote innovation and benefit patients across the kidney disease continuum.”.

肾脏护理合作伙伴主席、医学博士、公共卫生硕士、工商管理硕士马赫什·克里希南（Mahesh Krishnan）表示：“肾脏护理合作伙伴非常高兴地欢迎血液透析创新者Diality，他为我们的联盟带来了重要的声音。”。“我们共同期待着推动创新的举措，并使肾脏疾病连续体的患者受益。”

Diality is one of several members of Kidney Care Partners focused on innovation within kidney care, and the first pre-revenue medical device manufacturer among the new member organizations. Diality recently received 510(k) clearance for the Moda-flx Hemodialysis System.

Diality是肾脏护理合作伙伴中专注于肾脏护理创新的几家成员之一，也是新成员组织中第一家创收前医疗器械制造商。Diality最近获得了Moda flx血液透析系统的510（k）许可。

About Diality

关于Diality

Diality is a medical device company focused on developing solutions to improve lives impacted by kidney disease. The Moda-flx Hemodialysis System is a user-friendly, mobile, and connected hemodialysis platform designed to maximize clinical flexibility by combining prescription capabilities of in-center systems with the ease-of-use of next generation hemodialysis devices.

Diality是一家医疗器械公司，专注于开发解决方案，以改善受肾脏疾病影响的生活。Moda flx血液透析系统是一个用户友好的移动连接血液透析平台，旨在通过将中心系统的处方功能与下一代血液透析设备的易用性相结合，最大程度地提高临床灵活性。

Moda-flx Hemodialysis system obtained U.S. FDA clearance in August 2024. Please visit www.diality.com or find us on LinkedIn to learn more about Diality and the Moda-flx Hemodialysis System..

Moda flx血液透析系统于2024年8月获得美国FDA批准。请访问www.diality.com或在LinkedIn上找到我们，以了解有关diality和Moda flx血液透析系统的更多信息。

About Kidney Care Partners

关于肾脏护理合作伙伴

Kidney Care Partners (KCP) is a non-profit coalition of over 25 organizations, comprising patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant coordinators, and manufacturers. KCP members are committed to meeting patients’ needs at every stage along the care continuum, and our diverse membership shares a broad vision of KCP policy priorities.

肾脏护理合作伙伴（KCP）是由25多个组织组成的非营利性联盟，包括患者、透析专业人员、医生、护士、研究人员、治疗创新者、移植协调员和制造商。KCP成员致力于在整个护理过程的每个阶段满足患者的需求，我们不同的成员对KCP政策重点有着广泛的看法。

These priorities range across the full spectrum of the disease cycle from education and prevention to early intervention to dialysis and, finally, to transplant and post-transplant care. Additional information about KCP’s legislative priorities is available here..

这些优先事项涵盖从教育和预防到早期干预到透析，最后到移植和移植后护理的整个疾病周期。有关KCP立法优先事项的其他信息，请参见此处。